‘Islet-on-a-chip’ offers continuous monitoring of insulin-producing cells, indicating whether they have therapeutic value and are suitable for transplant. Miniature, automated, easy-to-use device improves decision making for clinicians. New method streamlines fundamental research into insulin-producing cells and insulin-stimulating compounds, and improves drug screening.